Ventyx biosciences to participate in the 35th annual piper sandler healthcare conference

San diego, nov. 21, 2023 (globe newswire) -- ventyx biosciences, inc. (nasdaq: vtyx) (“ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announced that company executives will participate in the upcoming 35th annual piper sandler healthcare conference.
VTYX Ratings Summary
VTYX Quant Ranking